Histone methyltransferase PRDM9 promotes survival of drug-tolerant persister cells in glioblastoma. - Joun GL; Kempe EG; Chen B; Sterling JR; Abbassi RH; Friess D; Singleton M; Choudhury C; Marian OC; du Preez WD; Recasens A; Clark T; et al. (Nature communications, 2025)